New acquisitions in Argentina
Ceva Santé Animale (Ceva) announces the acquisition of the Argentinian companies Zoovet – specialized in the production and marketing of animal health products and Biotecnofe – a biotech start-up developing innovative products to be distributed by Zoovet.
These strategic acquisitions will give Ceva access to a state-of-the-art biotechnology campus based in Santa Fe, Argentina. With 200 experts and a tight collaboration with the prestigious university of the city mentioned above, this campus will strengthen Ceva’s activities in Latin America to support pharmaceutical innovation, especially for ruminants.
As a result, Ceva will become the 5th largest player in Argentina, with 250 employees and an expected turnover of 35 million euros.
At Ceva, our priority is to develop innovative and effective solutions for animal health and welfare. This strategic buyout will help us to increase our footprint in Latin America, one of the world’s major animal protein producing regions. At Ceva, we are committed to providing solutions that help farmers to keep their animals healthy. This is the meaning of the work carried out by Zoovet and Biotecnofe, which has a proven track record as a biotechnology campus. Being innovative is not just about optimizing products, it’s also about finding new ways to create a positive impact for our society and our planet.”
Marc Prikazsky, President and CEO of Ceva Santé Animale.